Abbott’s blood test to predict chance of heart attack gets CE mark
Abbott has secured CE mark for its High Sensitive Troponin-I blood test, which will help predict the chance…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Abbott has secured CE mark for its High Sensitive Troponin-I blood test, which will help predict the chance…
Specialty pharmaceutical firm INSYS Therapeutics has completed a human proof-of-concept study of dronabinol inhalation using a patented breath-actuated…
Ancora Heart has unveiled encouraging initial safety data from its recently expanded early feasibility study of its investigational…
Allergan, a pharmaceutical firm focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine…
Medical device company Cardiovascular Systems (CSI) has unveiled the first worldwide commercial use of its minimally-invasive Stealth 360…
CSA Medical is planning to start worldwide pivotal study of RejuvenAir Metered Cryospray system in chronic bronchitis in…
Johnson & Johnson Medical Devices Companies, via its subsidiary Johnson & Johnson Medical, has acquired Emerging Implant Technologies…
CoreLink Surgical has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its M3 stand-alone…
Stryker has signed an agreement to acquire US-based medical technology firm Invuity for an equity value of around…
Medical device company LimaCorporate has agreed to acquire TechMah Medical for an undisclosed amount to expand its digital…